| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 9.9k | $0.00 | $0 | | 02/21/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 715 | $58.50 | $41.8k | | 02/21/2023 |
| 02/21/2023 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 14k | $35.46 | $497.3k | | 02/21/2023 |
| 01/27/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 542 | $52.77 | $28.6k | | 01/27/2023 |
| 01/20/2023 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 2k | $52.05 | $104.9k | | 01/20/2023 |
| 05/27/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 10k | $43.00 | $430k | | 04/21/2022 |
| 04/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Other (disposition) | Common Stock | 1.9k | $0.00 | $0 | | 04/21/2022 |
| 04/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Other (disposition) | Stock Option (Right to Buy) | 11.2k | $44.90 | $505.1k | | 04/21/2022 |
| 04/05/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 609 | $60.09 | $36.6k | | 04/05/2022 |
| 04/05/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 609 | $13.85 | $8.4k | | 04/05/2022 |
| 04/04/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $57.81 | $72.2k | | 04/04/2022 |
| 04/04/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.4k | $56.86 | $81.7k | | 04/04/2022 |
| 04/04/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 818 | $55.84 | $45.7k | | 04/04/2022 |
| 04/04/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 3.5k | $13.85 | $48.5k | | 04/04/2022 |
| 04/01/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 11.5k | $55.05 | $632.9k | | 04/01/2022 |
| 04/01/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 11.5k | $13.85 | $159.2k | | 04/01/2022 |
| 02/14/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 720 | $26.73 | $19.2k | | 02/14/2022 |
| 02/11/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.7k | $46.80 | $78k | | 02/11/2022 |
| 01/31/2022 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 1.2k | $38.47 | $47.4k | | 01/28/2022 |
| 01/28/2022 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 642 | $38.59 | $24.8k | | 01/28/2022 |
| 01/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 26.1k | $0.00 | $0 | | 01/21/2022 |
| 01/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 37k | $35.46 | $1.3M | | 01/21/2022 |
| 01/21/2022 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 3k | $26.73 | $80.8k | | 01/21/2022 |
| 06/10/2021 | Apellis Pharmaceuticals, Inc. | APLS | Sale | Common Stock | 3.4k | $60.00 | $205k | | 06/10/2021 |
| 02/10/2021 | Apellis Pharmaceuticals, Inc. | APLS | Payment of Exercise | Common Stock | 680 | $47.72 | $32.4k | | 02/10/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 7.5k | $0.00 | $0 | | 01/28/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 1.9k | $0.00 | $0 | | 01/28/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 45k | $44.90 | $2M | | 01/28/2021 |
| 01/28/2021 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (Right to Buy) | 11.2k | $44.90 | $505.1k | | 01/28/2021 |
| 12/08/2020 | Apellis Pharmaceuticals, Inc. | APLS | Exercise | Stock Option (Right to Buy) | 7.5k | $26.73 | $200k | | 12/08/2020 |
| 02/10/2020 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Common Stock | 9.4k | $0.00 | $0 | | 02/10/2020 |
| 02/10/2020 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock option (right to buy) | 56.2k | $44.33 | $2.5M | | 02/10/2020 |
| 02/08/2019 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock option (right to buy) | 85k | $13.85 | $1.2M | | 02/08/2019 |
| 05/24/2018 | Apellis Pharmaceuticals, Inc. | APLS | Purchase | Common Stock | 2.9k | $20.37 | $59.8k | | 05/24/2018 |
| 04/13/2018 | Apellis Pharmaceuticals, Inc. | APLS | Grant | Stock Option (right to buy) | 145k | $26.73 | $3.9M | | 04/13/2018 |
|